Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Polyhexanide
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Approved FDF
Sponsor : University of California
Deal Size : Undisclosed
Deal Type : Collaboration
SIFI, UCSF Collaborate on Acanthamoeba Keratitis Research
Details : The collaboration aims to evaluate the Akantior (polihexanide), the first and only approved drug for the treatment of AK. It is being indicated for the treatment of Acanthamoeba Keratitis in US.
Product Name : Akantior
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
March 18, 2025
Lead Product(s) : Polyhexanide
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved FDF
Sponsor : University of California
Deal Size : Undisclosed
Deal Type : Collaboration
Lead Product(s) : Polyhexanide,Edetate Calcium Disodium,Citric Acid
Therapeutic Area : Podiatry
Study Phase : Approved FDF
Sponsor : Best Buy Medical Canada
Deal Size : Undisclosed
Deal Type : Agreement
Kane Announces Canadian Distribution Agreement with Best Buy Medical for Revyve
Details : The agreement aims for the distribution of revyve, an antimicrobial wound gel product line in infection management and wound healing.
Product Name : Revyve
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
March 11, 2025
Lead Product(s) : Polyhexanide,Edetate Calcium Disodium,Citric Acid
Therapeutic Area : Podiatry
Highest Development Status : Approved FDF
Sponsor : Best Buy Medical Canada
Deal Size : Undisclosed
Deal Type : Agreement
Lead Product(s) : Polyhexanide
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
SIFI Updates AKANTIOR® Regulatory Pathway for Acanthamoeba Keratitis in UK and US
Details : Akantior (polihexanide) is an investigational anti-amoebic polymer that got approval from european medicines agency for the treament of acanthamoeba keratitis.
Product Name : Akantior
Product Type : Small molecule
Upfront Cash : Not Applicable
December 16, 2024
Lead Product(s) : Polyhexanide
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Lead Product(s) : Polyhexanide,Edetate Calcium Disodium,Citric Acid
Therapeutic Area : Podiatry
Study Phase : Approved
Sponsor : BioStem Technologies
Deal Size : Undisclosed
Deal Type : Partnership
Kane Biotech Changes US Partner for Revyve™ Antimicrobial Wound Gel Distribution
Details : BioStem Technologies will acquire exclusive US distribution rights for revyve from ProgenaCare Global.
Product Name : Undisclosed
Product Type : Small molecule
Upfront Cash : Undisclosed
November 27, 2024
Lead Product(s) : Polyhexanide,Edetate Calcium Disodium,Citric Acid
Therapeutic Area : Podiatry
Highest Development Status : Approved
Sponsor : BioStem Technologies
Deal Size : Undisclosed
Deal Type : Partnership
Lead Product(s) : Polyhexanide,Edetate Calcium Disodium,Citric Acid
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Kane Biotech Announces Health Canada Approval of revyve™ Antimicrobial Wound Gel
Details : Revyve Antimicrobial Wound Gel is indicated for management of ulcers (including diabetic foot and leg ulcers and pressure ulcers), burns, partial & full thickness wounds for adult populations.
Product Name : Revyve
Product Type : Small molecule
Upfront Cash : Not Applicable
November 14, 2024
Lead Product(s) : Polyhexanide,Edetate Calcium Disodium,Citric Acid
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Lead Product(s) : Polyhexanide,Edetate Calcium Disodium,Citric Acid
Therapeutic Area : Podiatry
Study Phase : Approved
Sponsor : Qatar Datamation Systems
Deal Size : Undisclosed
Deal Type : Agreement
Kane Biotech Signs Deal with Qatar Datamation For Wound Gel Distribution
Details : The agreement aims for the distribution of revyve antimicrobial wound gel indicated for diabetic foot ulcers, in the Qatar wound care market.
Product Name : Revyve
Product Type : Small molecule
Upfront Cash : Undisclosed
August 28, 2024
Lead Product(s) : Polyhexanide,Edetate Calcium Disodium,Citric Acid
Therapeutic Area : Podiatry
Highest Development Status : Approved
Sponsor : Qatar Datamation Systems
Deal Size : Undisclosed
Deal Type : Agreement
Lead Product(s) : Polyhexanide
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
SIFI Receives European Commission Approval for AKANTIOR®
Details : Akantior (polihexanide) is an investigational anti-amoebic polymer that got approval from european medicines agency for the treament of acanthamoeba keratitis.
Product Name : Akantior
Product Type : Small molecule
Upfront Cash : Not Applicable
August 26, 2024
Lead Product(s) : Polyhexanide
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Lead Product(s) : Polyhexanide
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
SIFI Receives Positive Opinion for Orphan Drug Designation for Polihexanide
Details : Akantior (polihexanide) is an investigational anti-amoebic polymer that recieved positive opinion from European Medicines Agency for the treament of acanthamoeba keratitis.
Product Name : Akantior
Product Type : Small molecule
Upfront Cash : Not Applicable
July 22, 2024
Lead Product(s) : Polyhexanide
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Lead Product(s) : Polyhexanide
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Avanzanite’s AKANTIOR® Gets Positive CHMP Opinion and Expands into 26 European Countries
Details : Akantior (polihexanide) is an investigational anti-amoebic polymer that recieved positive opinion from European Medicines Agency for the treament of acanthamoeba keratitis.
Product Name : Akantior
Product Type : Small molecule
Upfront Cash : Not Applicable
June 03, 2024
Lead Product(s) : Polyhexanide
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Lead Product(s) : Polyhexanide
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
SIFI Receives Positive CHMP Opinion for AKANTIOR in Acanthamoeba Keratitis
Details : Akantior® (polihexanide) is an investigational anti-amoebic polymer that recieved positive opinion from European Medicines Agency for the treament of acanthamoeba keratitis.
Product Name : Akantior
Product Type : Small molecule
Upfront Cash : Not Applicable
May 31, 2024
Lead Product(s) : Polyhexanide
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable